BIOMAT Database Logo BIOMAT Database Logo

Identification of critical residues for ligand binding in the integrin beta3 I-domain by site-directed mutagenesis. 2002

Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Department of Internal Medicine 1, Ehime University School of Medicine, Shigenobu, Japan.

To define the structural basis of ligand recognition by alphaIIb beta3, we conducted site-directed mutagenesis of residues located on the top surface of the beta3 I-domain that is homologous to the I-domain of several alpha subunits and contains a putative ligand binding site. Here we identify D158 and N215 in beta3 as novel residues critical for ligand binding. Alanine substitution of D158 or N215 abolished binding of a ligand-mimetic antibody and fibrinogen to alphaIIb beta3 induced by different types of integrin activation. CHO cells expressing recombinant alphaIIb beta3 bearing D158A or N215A mutation did not adhere to fibrinogen. These mutations had the same effect on ligand binding to another beta3 integrin, alphaVbeta3. Compared to the alphaI-domain structure, the betaB-betaC loop containing D158 in the beta3 I-domain is quite different in length and sequence. These results suggest that the structure for ligand recognition is different in the betaI- and alphaI-domains.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.
February 1998, European journal of biochemistry,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis.
September 1992, Biochemical and biophysical research communications,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Amino acid residues conferring ligand binding properties of prostaglandin I and prostaglandin D receptors. Identification by site-directed mutagenesis.
August 2000, The Journal of biological chemistry,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Critical residues for ligand binding in an I domain-like structure of the integrin beta1 subunit.
August 1996, The Journal of biological chemistry,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Identification of critical residues for plasminogen binding by the alphaX I-domain of the beta2 integrin, alphaXbeta2.
October 2007, Molecules and cells,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Identification of residues essential for progesterone binding to uteroglobin by site-directed mutagenesis.
January 1991, The Journal of steroid biochemistry and molecular biology,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Identification of critical residues of the mycobacterial dephosphocoenzyme a kinase by site-directed mutagenesis.
January 2011, PloS one,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis.
July 2005, The FEBS journal,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Active site residues in m-calpain: identification by site-directed mutagenesis.
July 1995, FEBS letters,
Jun Yamanouchi, and Takaaki Hato, and Tatsushiro Tamura, and Shigeru Fujita
Trichodiene synthase. Identification of active site residues by site-directed mutagenesis.
February 1995, Biochemistry,
Copied contents to your clipboard!